Harmony Biosciences scores victory over activist short seller Scorpion with U.S. Patent Office decision on Wakix


"Those who think that the initial ruling re-affirms Harmony’s intellectual property position are badly mistaken," Scorpion said in a statement.

Previous Dentsply Sirona adds to executive team at Ballantyne headquarters
Next CVS Health to cut nearly 200 jobs in Rhode Island